PLASMA METABOLITES OF RECEIVING HEIFERS AND THE RELATIONSHIP BETWEEN BOVINE RESPIRATORY DISEASE

Summary
Six hundred sixty-five crossbred beef heifers initially weighing 495 lb were used to evaluate rectal temperature and plasma glucose, lactate, and urea nitrogen at initial processing as indicators of health status of newly arrived receiving cattle. We also evaluated the relationship between bovine respiratory disease (BRD), weight gain, and carcass characteristics. An increased number of treatments for BRD was associated with lower (linear, P<0.01) plasma glucose and lactate concentrations at initial processing. Elevated rectal temperatures at initial processing were associated with a greater number of treatments for BRD (linear, P<0.03) . Initial body weight, final body weight, and average daily gain during the receiving period were progressively less (linear, P<0.01) as the number of treatments for BRD increased, whereas grazing-period gain was progressively greater with more frequent treatment for BRD during the receiving period (linear, P<0.01). Finishing-period gain, final body weight, hot carcass weight, fat thickness, and marbling score were linearly decreased (P<0.05) with increased treatment for BRD during the receiving period. These data suggest that initial plasma glucose and lactate concentrations might be associated with the health of newly arrived receiving cattle and that increased incidence of BRD in cattle is associated with lower weight gain and carcass quality.
Introduction
Bovine respiratory disease (BRD) continues to be a significant problem in receiving cattle. Stress associated with weaning, transport, commingling, processing, as well as feed and water deprivation, can compromise the immune system, thereby predisposing cattle to outbreaks of BRD. Antibiotic therapy is commonly employed to decrease the immediate impact of BRD on cattle performance; little is known, however, about the implications of BRD for subsequent growth performance and carcass values.
Current methods of BRD detection in receiving cattle consist of measuring rectal temperature and(or) visual appraisal of clinical symptoms. These methods are subjective and often lack the sensitivity necessary to detect BRD in its early stages of development. We theorized that the previously-mentioned stressors might affect plasma metabolites such as glucose, lactate, and urea nitrogen in newly arrived receiving cattle. The objectives of our study were to evaluate the association between rectal temperature, plasma glucose, lactate, and urea nitrogen measured at initial processing, and the incidence of BRD in newly arrived receiving cattle, as well as to evaluate the impact of BRD on subsequent growth performance and carcass characteristics of cattle.
Experimental Procedures
A total of 665 crossbred beef heifers initially weighing 495 lb was used in a completely randomized design. Heifers were processed within 24 hours of arrival, and processing included vaccination against common viral and clostridial diseases (Bovishield ® 4 and Fortress ® 7), recording of rectal temperature, treatment for internal and external parasites (Phoenectin ® ), and sampling of blood via jugular venipuncture for analysis of plasma glucose, lactate, and urea nitrogen concentrations.
Immediately after initial processing, heifers were assigned randomly to 28 pens, which contained 21 to 27 heifers depending upon pen size. Heifers were offered a diet containing 44% steam-flaked corn, 45% alfalfa hay, 6% corn steep liquor, 3.8% soybean meal, and 1.2% vitamins and minerals for ad libitum consumption. Heifers were subsequently monitored for clinical signs of BRD, including depression, lethargy, anorexia, coughing, rapid breathing, and nasal or ocular discharge. Heifers exhibiting signs of BRD received antibiotic therapy consisting of Micotil ® as a first-time and second-time treatment for BRD, and Liquamycin ® LA-200 ® and dexamethasone as a third-time treatment for BRD. The number of times a heifer was treated for BRD ranged between zero and three. After the 36-day receiving period, heifers were weighed, and six heifers identified as moribund were removed. The remaining heifers were implanted with Synovex C ® and transported to native grass pastures for a 136-day grazing period. At the end of the grazing season, cattle were transported to a commercial feedyard, where they were implanted with Component TH ® and offered a series of common diets for ad libitum consumption throughout a 124-day finishing period. At the end of the finishing period, heifers were transported to a commercial abattoir, where carcass data were collected. Final body weight was calculated by dividing hot-carcass weight by a common dressing percentage of 63.5%. These adjusted final weights were used to compute daily gains for each group of heifers.
Results and Discussion
Plasma glucose and lactate concentrations at initial processing were greater (P<0.01) for heifers not treated for BRD than for heifers subsequently treated for BRD, and they became increasingly lower (linear, P<0.01) as the number of times heifers were treated for BRD increased (Table 1) . Heifers subsequently treated for BRD had lower initial plasma glucose and lactate concentrations, suggesting that their energy stores might have been less than that of healthy heifers, thereby possibly preventing them from mounting an effective immune response. Rectal temperature at initial processing increased (linear, P<0.03) with the number of times heifers were subsequently treated for BRD, although the range among group averages was only 0.23°F. Initial plasma glucose and lactate concentrations were negatively correlated with morbidity (r = -0.20, P<0.01 for glucose, and r = -0.14, P<0.01 for lactate; Table 2 ), indicating that, as initial plasma glucose and lactate concentrations increased, subsequent morbidity decreased. Although rectal temperature at initial processing was not significantly correlated with morbidity (r = 0.04, P>0.34), it was positively correlated with death loss (r = 0.12, P<0.01).
An increased number of treatments for BRD during the receiving period was linearly related to lesser (P<0.01) initial body weight, final body weight, and daily gains during the receiving period (Table 3 ), suggesting that lighter heifers were more susceptible to BRD infection and that BRD decreased weight gain during the receiving period. Grazing-period daily gains (Table 3) were linearly increased (P<0.01) with increased number of treatments for BRD, possibly as a result of less gastrointestinal tract fill at the start of the grazing period because of reduced feed intake during the receiving period. Finishing-period gain, final body weight (Table 3) , hot-carcass weight, fat thickness, and marbling score (Table 4) were decreased linearly (P<0.05) with increased number of treatments for BRD during the receiving period. The percentage of USDA Yield Grade 1 carcasses increased linearly (P<0.04) with increased number of treatments for BRD, whereas the percentage of USDA Yield Grade 3 carcasses decreased (quadratic, P<0.04). Because all heifers were marketed on a pen basis, the effect of BRD on USDA Yield Grade 3 carcasses was the result of delaying the marketing of healthier heifers to allow heifers previously treated for BRD to reach a marketable endpoint.
Marketing healthier cattle earlier might avoid possible discounts from less favorable USDA Yield Grades. Total weight gain during the entire 296-day experiment was linearly decreased (P<0.04) with increased number of treatments for BRD during the receiving period, demonstrating the long-lasting effects that BRD infection can have on subsequent cattle weight gain.
These data suggest that initial plasma glucose and lactate concentrations are correlated with the health status of newly arrived receiving cattle; because of their great variability, however, glucose and lactate concentrations were not very efficacious in identifying individual cattle at risk for BRD infection. These data also indicate that increased incidence of BRD in cattle decreases growth rate and carcass quality. 
